Drugs / soluble human insulin
soluble human insulin
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 43 trials | ||||||
| Phase 4 | NCT00593255 | Jul 2004 → Apr 2005 | type 1 diabetes mellitus, type 2 diabetes mellitus | Novo Nordisk A/S | Completed | No outcome recorded |
| Phase 4 | NCT00571935 | Aug 2003 → Oct 2004 | type 1 diabetes mellitus | Novo Nordisk A/S | Completed | No outcome recorded |
| Phase 4 | NCT00597233 | Oct → Dec 2002 | type 1 diabetes mellitus | Novo Nordisk A/S | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT00410033 | Dec 1989 → May 2006 | type 1 diabetes mellitus | Novo Nordisk A/S | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | soluble human insulin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00597233 ↗ |
| Known as | human insulin | “or human insulin (HI)” PMID 20388052 ↗ May 2010 |
| Known as | Novolin R | “Human Soluble Insulin (Novolin® R)” NCT00593255 ↗ |